KLF4 Induces Colorectal Cancer by Promoting EMT via STAT3 Activation

Lebin Yuan1, Yanqiu Meng2, Jiajia Xiang3

  • 1Department of Nail and Breast Surgery, Affiliated Xiangyang Central Hospital of Hubei University of Arts and Science, Xiangyang Center Hospital, Xiangyang, Hubei, China.

Abstract

Insights

Krüppel-like factor 4 (KLF4) promotes colorectal cancer (CRC) progression by activating STAT3 signaling, leading to increased proliferation, invasion, and epithelial-mesenchymal transition (EMT). This study elucidates KLF4

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Krüppel-like factor 4 (KLF4) is implicated in solid tissue carcinogenesis.
  • Its specific role and mechanisms in colorectal cancer (CRC) require further elucidation.

Purpose of the Study:

  • To investigate the role of KLF4 in CRC proliferation and invasion.
  • To explore the underlying molecular mechanisms involving KLF4 in CRC progression.

Main Methods:

  • Immunohistochemistry and immunoblotting to assess KLF4 expression and clinical significance.
  • In vitro and xenograft models to examine KLF4's effect on tumor growth, proliferation, invasion, and epithelial-mesenchymal transition (EMT).
  • Bioinformatic analyses (JASPAR, GSEA) and molecular experiments to determine KLF4's interaction with the STAT3 signaling pathway.

Main Results:

  • KLF4 expression is downregulated in CRC and correlates with vessel invasion, advanced TNM stage, and poorer prognosis.
  • KLF4 overexpression promotes CRC cell proliferation, invasion, and EMT.
  • KLF4 activates STAT3 signaling by binding to its promoter, which mediates KLF4's oncogenic effects.

Conclusions:

  • KLF4 plays a significant role in promoting CRC progression.
  • KLF4 activates STAT3 signaling, driving EMT and enhancing tumor aggressiveness.
  • Targeting KLF4 or STAT3 may offer therapeutic strategies for CRC.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.4K